Anil Kumble Brand Ambassador for Changing Diabetes® Attends the 73rd Annual Conference
by Shrutee K/DNS
Bengaluru, 23
February 2018. Anil
Kumble, Changing
Diabetes® brand ambassador and former captain and coach of the Indian men’s
cricket team inaugurated an ‘Insulin Symposium’ organised by Novo
Nordisk, a global leader in diabetes care, today at the 73rd Annual
Conference of Association of Physicians of India (APICON) in Bengaluru.
The symposium comes on the back of Novo
Nordisk’s renewed commitment to educate the physician community on advancements
in diabetes treatment. The need for reaching out stems from a strong engagement
between the patients and physicians. Usually, physicians are one of the first
to diagnose diabetes and can play a key role in improving patients’ diabetes
related literacy.
According to IDF Atlas 8th
edition, 72.9 million people have diabetes in India and over 58% people have
undiagnosed diabetes. In his opening address at the symposium, Anil Kumble said: “Diabetes in India is on the rise.
I am glad that I have the opportunity to be a part of the Changing Diabetes®
mission spearheaded by Novo Nordisk India. To manage diabetes, it is essential
that one gets timely diagnosis and early initiation of treatment combined with
simple lifestyle modifications. As physicians, I urge you to motivate people to
recognise the need to know their risk at the earliest for managing diabetes
better.” The workshop conducted by leading city-based
diabetologists focused on increasing the participating physicians’ knowledge
about the progression of diabetes, the physiological effects of insulin, and
tools for successfully initiating insulin in patients with type 2 diabetes. Approximately
300 doctors benefitted from this.
Melvin D’souza,
Managing Director, Novo Nordisk India said: “Novo Nordisk is committed towards
creating awareness about diabetes and ensuring people with diabetes are
provided with best-in-class quality medication. APICON is the right platform
for healthcare professionals to congregate and converse on the latest in
diabetes care treatment and best practices. We are happy to support API
Karnataka Chapter in their endeavour to create a platform to ideate, debate and
share scientific updates on diabetes.”
Dr.
M. Maiya, Chairman, Organizing Committee APICON 2018 said: “API was established in 1944
with the aim of promoting collaboration, enabling knowledge sharing, advancing
treatment practices and skills, and supporting academic endeavour in the field
of medicine in India, by conducting its annual national conferences in various
cities of India.”
APICON 2018 being held in Bengaluru is one of the
largest conferences with the registered delegates tally of around 10,000 The
conference featured lectures, interactive workshops and discussions with many
prominent and renowned physicians.
About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of
innovation and leadership in diabetes care. This heritage has given us
experience and capabilities that also enable us to help people defeat obesity,
haemophilia, growth disorders and other serious chronic diseases. Headquartered
in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries
and markets its products in more than 165 countries. For more information,
visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.
Comments
Post a Comment